Trump Reminds America He’s Still the Marijuana Logic Guy, Kind Of

KEY POINTS

•President Trump signed an executive order in December 2025 shifting marijuana to Schedule III, easing research restrictions.
•He claimed the change responds to pleas from people with extreme pain and aims to substitute dangerous opioid painkillers.
•Cannabis stocks jumped significantly after the announcement, reflecting investor optimism amid Trump’s new, friendlier stance on marijuana.

On an unforgettable December Thursday in 2025, President Donald Trump, surrounded by serious-looking doctors who probably wondered if this was really their day, signed an executive order bumping marijuana from Schedule I – AKA 'no medical use, high abuse' – to Schedule III, grouping it with ketamine and anabolic steroids. Trump proclaimed the move was inspired by 'people begging' for relief from agonizing pain and noted mildly that the reclassification would ease research (and maybe federal tax headaches for pot businesses). Stocks like Tilray, Aurora Cannabis, and Canopy Growth reacted as if they won the lottery, surging 6%, 9%, and 11% respectively. Meanwhile, Trump's 2024 campaign declared a new 'common sense' era with promises to support Florida’s near-miss 56% vote on recreational use, proving that friendly nods to grass might just compete with his soufflé soufflé political career.

Share the Story

(1 of 3)

Mockingbird News

@MockingbirdNews · now

Trump moves weed to Schedule III, lumping pot with ketamine steroids because science is now a casual suggestion. Meanwhile, cannabis stocks party harder than most Americans about his common sense.

213/280 charactersReady to post